Historic vaccine factory in Germany to close in 2028
A long-standing vaccine factory located in Germany is closing its doors. The plant, based in the city of Dresden, has been producing vaccines for a total of 115 years, but operations will officially end by the middle of 2028.
The closure of the factory marks a significant shift in the pharmaceutical industry. The facility has been an important part of the region's industrial history and employment for over a century. The decision to cease production has drawn attention, as the factory has been one of Germany's most well-known players in the pharmaceutical sector.
Although this is a German factory, the news has also sparked international discussion. Pharmaceutical and vaccine supply chains are global, and the closure of large production facilities often affects the availability and price levels of medicines elsewhere in Europe, including Finland.
The pharmaceutical company has not yet disclosed the exact reasons for the factory's closure, but the industry is constantly changing with the development of technology. Many older factories no longer meet modern requirements, which leads to the consolidation of production into more modern facilities.
Over the coming years, the factory's employees and local authorities will seek solutions to secure employment. At the same time, healthcare experts are monitoring the situation to ensure that changes in vaccine production do not cause disruptions to the supply of essential medicines.